Korean ginseng (Panax ginseng Meyer) is a perennial herb prone to various root diseases with Phytophthora cactorum as one of the most dreaded disease causing foliar blight and root rot. Although chemical pesticides are available for disease control, attention has been shifted to viable, eco-friendly and cost-effective biological means like plant growth promoting rhizobacteria (PGPR) for control of diseases.

Ginseng total saponin (GTS) has been shown to possess various ginsenosides. These ginsenosides is widely used for treating cardiovascular diseases in Asian communities. The aim of this study was to study the effects of GTS on cardiac injury after the global ischemia and reperfusion (I/R) in isolated guinea pig hearts.

Ginseng has long been used as a functional food or therapeutic supplement and it is empirically known to be safe and non-toxic. During the past decades or so, a number of in vitro and in vivo experiments, as well as human studies have been conducted to prove the safety of various types of ginseng samples and their components.

Ginsenoside Rb1 (G-Rb1), the major active constituent of ginseng, improves insulin sensitivity and exerts anti-diabetic effects. We tested whether the insulin-sensitizing and anti-diabetic effects of G-Rb1 results from a reduction in ectopic fat accumulation, mediated by inhibition of lipolysis in adipocytes.